|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0070166,
umls-concept:C0178602,
umls-concept:C0288672,
umls-concept:C0333186,
umls-concept:C0439608,
umls-concept:C0522523,
umls-concept:C0522776,
umls-concept:C0687568,
umls-concept:C0936012,
umls-concept:C1522318,
umls-concept:C1550147,
umls-concept:C1708715,
umls-concept:C1948041,
umls-concept:C2346689
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-6-19
|
|
pubmed:abstractText |
ISAR-REACT was a trial designed to evaluate whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention (PCI) with stent placement after pretreatment with a 600 mg loading dose of clopidogrel. Objective for the angiographic substudy was to determine the impact of abciximab on angiographic restenosis after coronary stent placement. Previous analyses have suggested a reduction in the incidence of restenosis after the administration of abciximab.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
151
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1248-54
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16781230-Aged,
pubmed-meshheading:16781230-Angioplasty, Balloon, Coronary,
pubmed-meshheading:16781230-Antibodies, Monoclonal,
pubmed-meshheading:16781230-Coronary Angiography,
pubmed-meshheading:16781230-Coronary Restenosis,
pubmed-meshheading:16781230-Double-Blind Method,
pubmed-meshheading:16781230-Female,
pubmed-meshheading:16781230-Humans,
pubmed-meshheading:16781230-Immunoglobulin Fab Fragments,
pubmed-meshheading:16781230-Male,
pubmed-meshheading:16781230-Platelet Aggregation Inhibitors,
pubmed-meshheading:16781230-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:16781230-Stents,
pubmed-meshheading:16781230-Ticlopidine
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
|
|
pubmed:affiliation |
Deutsches Herzzentrum, Munich, Germany. schuehlen@dhm.mhn.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
